Stay updated on Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications section wording was updated to clarify PubMed autofill may not reflect the study, the previous PubMed-generated note was removed, and the revision number at the bottom was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-25T10:51:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. It previously warned that information might not be up to date and inquiries might not be processed until appropriations were enacted.
    Difference
    0.1%
    Check dated 2025-11-18T06:58:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Compared with the prior screenshot, there are no changes to core study information (title, eligibility criteria, outcomes, enrollment); observed differences appear to be minor UI/layout refinements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:05:49.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Location region renamed (Rhône-Alpes -> Auvergne-Rhône-Alpes) and revision updated to v3.2.0; Lyon address adjusted to the new region.
    Difference
    5%
    Check dated 2025-10-06T05:19:21.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T03:01:10.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change; overall, the substantive update is the version bump.
    Difference
    0.1%
    Check dated 2025-09-14T18:55:19.000Z thumbnail image

Stay in the know with updates to Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.